|
Mochida Pharmaceutical Co., Ltd. (4534.T) Avaliação DCF |
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Mochida Pharmaceutical Co., Ltd. (4534.T) Bundle
Ganhe domínio sobre sua análise de avaliação Mochida Pharmaceutical Co., Ltd. (4534T) usando nossa calculadora DCF de última geração! Este modelo do Excel é pré -carregado com dados reais (4534T), permitindo que você ajuste as previsões e suposições para determinar com precisão o valor intrínseco da Mochida Pharmaceutical Co., Ltd.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 101,801.0 | 102,995.0 | 110,179.0 | 103,261.0 | 102,885.0 | 103,272.1 | 103,660.7 | 104,050.7 | 104,442.2 | 104,835.1 |
| Revenue Growth, % | 0 | 1.17 | 6.98 | -6.28 | -0.36413 | 0.37624 | 0.37624 | 0.37624 | 0.37624 | 0.37624 |
| EBITDA | 11,538.0 | 14,746.0 | 17,281.0 | 11,715.0 | 8,973.0 | 12,682.2 | 12,729.9 | 12,777.8 | 12,825.9 | 12,874.2 |
| EBITDA, % | 11.33 | 14.32 | 15.68 | 11.35 | 8.72 | 12.28 | 12.28 | 12.28 | 12.28 | 12.28 |
| Depreciation | 2,731.0 | 2,742.0 | 2,689.0 | 2,672.0 | 2,808.0 | 2,706.2 | 2,716.4 | 2,726.6 | 2,736.9 | 2,747.2 |
| Depreciation, % | 2.68 | 2.66 | 2.44 | 2.59 | 2.73 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 |
| EBIT | 8,807.0 | 12,004.0 | 14,592.0 | 9,043.0 | 6,165.0 | 9,976.0 | 10,013.5 | 10,051.2 | 10,089.0 | 10,127.0 |
| EBIT, % | 8.65 | 11.65 | 13.24 | 8.76 | 5.99 | 9.66 | 9.66 | 9.66 | 9.66 | 9.66 |
| Total Cash | 61,290.0 | 63,486.0 | 61,914.0 | 60,509.0 | 46,789.0 | 58,269.2 | 58,488.4 | 58,708.4 | 58,929.3 | 59,151.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 28,448.0 | 29,189.0 | 31,676.0 | 27,806.0 | .0 | 23,125.2 | 23,212.2 | 23,299.5 | 23,387.2 | 23,475.2 |
| Account Receivables, % | 27.94 | 28.34 | 28.75 | 26.93 | 0 | 22.39 | 22.39 | 22.39 | 22.39 | 22.39 |
| Inventories | 25,073.0 | 22,605.0 | 23,127.0 | 24,404.0 | 30,278.0 | 24,915.4 | 25,009.1 | 25,103.2 | 25,197.7 | 25,292.5 |
| Inventories, % | 24.63 | 21.95 | 20.99 | 23.63 | 29.43 | 24.13 | 24.13 | 24.13 | 24.13 | 24.13 |
| Accounts Payable | 12,606.0 | 8,477.0 | 10,656.0 | 9,047.0 | 10,975.0 | 10,268.0 | 10,306.7 | 10,345.5 | 10,384.4 | 10,423.5 |
| Accounts Payable, % | 12.38 | 8.23 | 9.67 | 8.76 | 10.67 | 9.94 | 9.94 | 9.94 | 9.94 | 9.94 |
| Capital Expenditure | -1,958.0 | -2,088.0 | -3,096.0 | -2,166.0 | -2,296.0 | -2,290.5 | -2,299.2 | -2,307.8 | -2,316.5 | -2,325.2 |
| Capital Expenditure, % | -1.92 | -2.03 | -2.81 | -2.1 | -2.23 | -2.22 | -2.22 | -2.22 | -2.22 | -2.22 |
| Tax Rate, % | 26.19 | 26.19 | 26.19 | 26.19 | 26.19 | 26.19 | 26.19 | 26.19 | 26.19 | 26.19 |
| EBITAT | 6,455.4 | 8,662.0 | 10,569.7 | 6,648.3 | 4,550.7 | 7,287.0 | 7,314.4 | 7,341.9 | 7,369.6 | 7,397.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -33,686.6 | 6,914.0 | 9,332.7 | 8,138.3 | 28,922.7 | -10,766.8 | 7,589.5 | 7,618.1 | 7,646.8 | 7,675.5 |
| WACC, % | 5.03 | 5.03 | 5.03 | 5.03 | 5.03 | 5.03 | 5.03 | 5.03 | 5.03 | 5.03 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 15,490.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 7,829 | |||||||||
| Terminal Value | 258,044 | |||||||||
| Present Terminal Value | 201,857 | |||||||||
| Enterprise Value | 217,347 | |||||||||
| Net Debt | -33,290 | |||||||||
| Equity Value | 250,637 | |||||||||
| Diluted Shares Outstanding, MM | 36 | |||||||||
| Equity Value Per Share | 6,988.74 |
Benefits You Will Receive
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-filled financials for Mochida Pharmaceutical Co., Ltd. (4534T).
- Accurate Data: Access to historical data and forward-looking projections (highlighted in the yellow cells).
- Flexible Forecasting: Easily adjust forecast assumptions such as revenue growth, EBITDA percentage, and WACC.
- Instant Calculations: Quickly observe how your inputs influence the valuation of Mochida Pharmaceutical Co., Ltd. (4534T).
- Professional-Grade Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Format: Organized for clear understanding and ease of use, complete with step-by-step guidance.
Key Features
- Real-Time 4534T Data: Equipped with Mochida Pharmaceutical’s historical financial performance and future projections.
- Completely Adjustable Variables: Modify revenue growth rates, profit margins, discount rates, tax obligations, and capital investments.
- Interactive Valuation Framework: Instant updates to Net Present Value (NPV) and intrinsic valuation based on your adjustments.
- Scenario Analysis: Develop multiple forecasting scenarios to explore varying valuation results.
- Intuitive User Interface: Designed for ease of use, catering to both seasoned professionals and novices.
How It Functions
- Download the Template: Gain immediate access to the Excel-based Mochida Pharmaceutical DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells to set your growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Mochida’s intrinsic value with your inputs.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial strategies.
Why Opt for Mochida Pharmaceutical's Calculator?
- Time Efficient: Skip the hassle of building a DCF model from scratch – it’s fully prepared for immediate use.
- Enhanced Precision: Dependable financial data and formulas minimize valuation errors.
- Completely Customizable: Adjust the model to align with your specific assumptions and forecasts.
- User-Friendly: Intuitive charts and outputs facilitate straightforward analysis of the results.
- Endorsed by Professionals: Crafted for experts who prioritize accuracy and ease of use.
Who Should Consider Using This Product?
- Professional Investors: Develop comprehensive and reliable valuation models for analyzing portfolios focused on Mochida Pharmaceutical Co., Ltd. (4534T).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights regarding Mochida Pharmaceutical Co., Ltd. (4534T) to clients.
- Students and Educators: Utilize real-world data for practicing and teaching financial modeling techniques.
- Pharmaceutical Enthusiasts: Gain insights into how companies like Mochida Pharmaceutical Co., Ltd. (4534T) are valued within the industry.
Contents of the Template
- Detailed DCF Model: An editable template featuring thorough valuation calculations.
- Actual Financial Data: Preloaded historical and projected financials for Mochida Pharmaceutical Co., Ltd. (4534T) for in-depth analysis.
- Adjustable Assumptions: Modify WACC, growth rates, and tax rates to explore various scenarios.
- Comprehensive Financial Statements: Complete annual and quarterly reports for enhanced understanding.
- Essential Ratios: Integrated assessments for profitability, efficiency, and leverage metrics.
- Visual Dashboard: Graphs and tables designed for intuitive, actionable insights.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.